<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
    <url>
    <loc>https://stage.gyruscapital.com/news/accenture-completes-acquisition-of-lntellera-consulting</loc>
    <lastmod>2025-09-26T07:22:37+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-acquires-a-majority-stake-in-acbc-1</loc>
    <lastmod>2025-09-01T15:14:55+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/stepstone-group-provides-liquidity-solution-to-gyrus-capitals-lps-in-a-multi-asset-secondary-transaction-involving-dss-and-essential-pharma</loc>
    <lastmod>2025-09-01T15:15:14+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-raises-eur600m-continuation-fund</loc>
    <lastmod>2025-09-01T15:15:30+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-investment-into-neo-medical</loc>
    <lastmod>2025-09-01T15:15:53+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/dss-acquires-global-infrastructure-advisory-firm-infrata</loc>
    <lastmod>2025-09-01T15:16:12+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/lre-medical-announces-appointment-of-new-chief-executive-officer</loc>
    <lastmod>2025-09-01T15:16:32+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-is-delighted-to-share-its-inaugural-2023-sustainability-report</loc>
    <lastmod>2025-09-01T15:16:51+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/homnya-announces-acquisition-of-editoriale-giornalidea</loc>
    <lastmod>2025-09-01T15:17:07+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-agrees-to-sell-intellera-to-accenture-nyse-acn</loc>
    <lastmod>2025-09-01T15:17:29+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/essential-pharma-acquires-renaissance-pharma-ltd-with-its-clinical-stage-immunotherapy-for-the-treatment-of-high-risk-neuroblastoma-2-apr-2024</loc>
    <lastmod>2025-09-01T15:17:44+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/intellera-expands-internationally-with-the-acquisition-of-predictby-in-spain</loc>
    <lastmod>2025-09-01T15:17:59+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/essential-pharma-acquires-european-rights-to-colobreathe-colistimethate-sodium-from-teva</loc>
    <lastmod>2025-09-01T15:18:47+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-holds-final-close-on-gyrus-capital-fund-ii</loc>
    <lastmod>2025-09-01T15:19:03+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/intellera-consulting-acquires-trust4value-to-grow-on-artificial-intelligence-and-machine-learning</loc>
    <lastmod>2025-09-01T15:19:22+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/dss-acquires-ads-system-safety-consulting</loc>
    <lastmod>2025-09-01T15:19:45+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/essential-pharma-appoints-lee-morley-as-non-executive-director-to-the-board</loc>
    <lastmod>2025-09-01T15:20:07+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-agrees-to-acquire-lre-medical-from-ais-global</loc>
    <lastmod>2025-09-01T15:20:24+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/inflexion-acquires-majority-stake-in-dss-from-gyrus-capital</loc>
    <lastmod>2025-09-01T15:20:43+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/essential-pharma-announces-the-acquisition-of-haldol</loc>
    <lastmod>2025-09-01T15:20:58+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-acquires-40-of-consulcesi-group</loc>
    <lastmod>2025-09-01T15:21:14+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-to-acquire-consulcesi-group-with-founder-management</loc>
    <lastmod>2025-09-01T15:21:36+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-to-acquire-majority-stake-in-katalist-group</loc>
    <lastmod>2025-09-01T15:21:58+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/dss-acquires-perfect-food-consulting</loc>
    <lastmod>2025-09-01T15:22:15+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/dupont-sustainable-solutions-unveils-new-brand-name-dss</loc>
    <lastmod>2025-09-01T15:22:28+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/corcym-announces-growth-financing-to-accelerate-international-expansion-and-strategic-growth-initiatives</loc>
    <lastmod>2025-09-01T15:22:38+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/essential-pharma-completes-refinancing-and-two-significant-ma-transactions</loc>
    <lastmod>2025-09-01T15:22:52+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/dupont-sustainable-solutions-announces-new-members-to-board-of-directors</loc>
    <lastmod>2025-09-01T15:23:05+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-backed-dupont-sustainable-solutions-acquires-sofies-group</loc>
    <lastmod>2025-09-01T15:23:19+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
    <url>
    <loc>https://stage.gyruscapital.com/news/gyrus-capital-closes-debut-gyrus-investment-programme</loc>
    <lastmod>2025-09-01T15:23:30+00:00</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
            </url>
</urlset>
